MARKET

ANTH

ANTH

Anthera Pharmace
EXMKT
0.0001
0.0000
0.00%
Closed 16:00 09/30 EDT
OPEN
--
PREV CLOSE
0.0001
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
0.090
52 WEEK LOW
0.0000
MARKET CAP
2.62K
P/E (TTM)
-0.0001
1D
5D
1M
3M
1Y
5Y
No Data
About ANTH
Anthera Pharmaceuticals, Inc. (Anthera) is a biopharmaceutical company focused on developing and commercializing products to treat serious diseases associated with inflammation, including enzyme replacement therapies and autoimmune diseases. The Company has two Phase III product candidates, liprotamase also known as Sollpura and blisibimod. Sollpura is a non-porcine investigational Pancreatic Enzyme Replacement Therapy (PERT) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (EPI), often seen in patients with cystic fibrosis and other conditions. Blisibimod targets B-cell activating factor (BAFF), which has been shown to be elevated in a range of B-cell mediated autoimmune diseases, including systemic lupus erythematosus (SLE), or lupus, Immunoglobulin A nephropathy (IgA) nephropathy, lupus nephritis and others.

Webull offers kinds of Anthera Pharmaceuticals Inc stock information, including EXMKT:ANTH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ANTH stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ANTH stock methods without spending real money on the virtual paper trading platform.